{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:21:53Z","timestamp":1767676913542,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130017","81830016","81771732","81922010","81873561","81570469"],"award-info":[{"award-number":["82130017","81830016","81771732","81922010","81873561","81570469"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020732","name":"Innovative Research Team of High-level Local University in Shanghai","doi-asserted-by":"publisher","award":["SHSMU-ZDCX20210301"],"award-info":[{"award-number":["SHSMU-ZDCX20210301"]}],"id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019087","name":"Shanghai Municipal Human Resources Development Program for Outstanding Leaders in Medical Disciplines","doi-asserted-by":"publisher","award":["20XD1422500"],"award-info":[{"award-number":["20XD1422500"]}],"id":[{"id":"10.13039\/501100019087","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support","award":["20161311"],"award-info":[{"award-number":["20161311"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00535-023-02045-z","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T16:02:12Z","timestamp":1697472132000},"page":"66-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MGAT5\/TMEM163 variant is associated with prognosis in ursodeoxycholic acid-treated patients with primary biliary cholangitis"],"prefix":"10.1007","volume":"59","author":[{"given":"Hanxiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiting","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9616-4672","authenticated-orcid":false,"given":"Xiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"2045_CR1","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(20)31607-X","volume":"396","author":"A Lleo","year":"2020","unstructured":"Lleo A, Wang GQ, Gershwin ME, et al. Primary biliary cholangitis. Lancet. 2020;396:1915\u201326.","journal-title":"Lancet"},{"key":"2045_CR2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145\u201372.","journal-title":"J Hepatol"},{"key":"2045_CR3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","volume":"69","author":"KD Lindor","year":"2019","unstructured":"Lindor KD, Bowlus CL, Boyer J, et al. primary biliary cholangitis: 2018 practice guidance from the American Association for the study of liver diseases. Hepatology. 2019;69:394\u2013419.","journal-title":"Hepatology"},{"key":"2045_CR4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41395-018-0390-3","volume":"114","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Bernstein D, Shiffman ML, et al. Diagnosis and management of primary biliary cholangitis. Am J Gastroenterol. 2019;114:48\u201363.","journal-title":"Am J Gastroenterol"},{"key":"2045_CR5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","volume":"17","author":"AF Gulamhusein","year":"2020","unstructured":"Gulamhusein AF, Hirschfield GM. Primary biliary cholangitis: pathogenesis and therapeutic opportunities. Nat Rev Gastroenterol Hepatol. 2020;17:93\u2013110.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2045_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","volume":"128","author":"C Corpechot","year":"2005","unstructured":"Corpechot C, Carrat F, Bahr A, et al. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology. 2005;128:297\u2013303.","journal-title":"Gastroenterology"},{"key":"2045_CR7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","volume":"71","author":"MH Harms","year":"2019","unstructured":"Harms MH, van Buuren HR, Corpechot C, et al. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. J Hepatol. 2019;71:357\u201365.","journal-title":"J Hepatol"},{"key":"2045_CR8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2468-1253(19)30343-7","volume":"5","author":"RA Shah","year":"2020","unstructured":"Shah RA, Kowdley KV. Current and potential treatments for primary biliary cholangitis. Lancet Gastroenterol Hepatol. 2020;5:306\u201315.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2045_CR9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","volume":"130","author":"A Par\u00e9s","year":"2006","unstructured":"Par\u00e9s A, Caballer\u00eda L, Rod\u00e9s J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology. 2006;130:715\u201320.","journal-title":"Gastroenterology"},{"key":"2045_CR10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","volume":"48","author":"C Corpechot","year":"2008","unstructured":"Corpechot C, Abenavoli L, Rabahi N, et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology. 2008;48:871\u20137.","journal-title":"Hepatology"},{"key":"2045_CR11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","volume":"136","author":"EM Kuiper","year":"2009","unstructured":"Kuiper EM, Hansen BE, de Vries RA, et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology. 2009;136:1281\u20137.","journal-title":"Gastroenterology"},{"key":"2045_CR12","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","volume":"105","author":"T Kumagi","year":"2010","unstructured":"Kumagi T, Guindi M, Fischer SE, et al. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am J Gastroenterol. 2010;105:2186\u201394.","journal-title":"Am J Gastroenterol"},{"key":"2045_CR13","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","volume":"55","author":"C Corpechot","year":"2011","unstructured":"Corpechot C, Chazouill\u00e8res O, Poupon R. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. J Hepatol. 2011;55:1361\u20137.","journal-title":"J Hepatol"},{"key":"2045_CR14","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","volume":"149","author":"WJ Lammers","year":"2015","unstructured":"Lammers WJ, Hirschfield GM, Corpechot C, et al. Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy. Gastroenterology. 2015;149:1804-1812.e4.","journal-title":"Gastroenterology"},{"key":"2045_CR15","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","volume":"63","author":"M Carbone","year":"2016","unstructured":"Carbone M, Sharp SJ, Flack S, et al. The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Hepatology. 2016;63:930\u201350.","journal-title":"Hepatology"},{"key":"2045_CR16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S2468-1253(18)30163-8","volume":"3","author":"M Carbone","year":"2018","unstructured":"Carbone M, Nardi A, Flack S, et al. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score. Lancet Gastroenterol Hepatol. 2018;3:626\u201334.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2045_CR17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12072-022-10431-7","volume":"17","author":"C Yang","year":"2023","unstructured":"Yang C, Guo G, Li B, et al. Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion. Hepatol Int. 2023;17:237\u201348.","journal-title":"Hepatol Int"},{"key":"2045_CR18","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/hep.29059","volume":"65","author":"Z Shuai","year":"2017","unstructured":"Shuai Z, Wang J, Badamagunta M, et al. The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitis. Hepatology. 2017;65:1670\u201382.","journal-title":"Hepatology"},{"key":"2045_CR19","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/hep.29245","volume":"66","author":"T Tanaka","year":"2017","unstructured":"Tanaka T, Zhang W, Sun Y, et al. Autoreactive monoclonal antibodies from patients with primary biliary cholangitis recognize environmental xenobiotics. Hepatology. 2017;66:885\u201395.","journal-title":"Hepatology"},{"key":"2045_CR20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cld.2018.03.002","volume":"22","author":"A Tanaka","year":"2018","unstructured":"Tanaka A, Leung PSC, Gershwin ME. The genetics and epigenetics of primary biliary cholangitis. Clin Liver Dis. 2018;22:443\u201355.","journal-title":"Clin Liver Dis"},{"key":"2045_CR21","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jhep.2021.04.055","volume":"75","author":"HJ Cordell","year":"2021","unstructured":"Cordell HJ, Fryett JJ, Ueno K, et al. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs. J Hepatol. 2021;75:572\u201381.","journal-title":"J Hepatol"},{"key":"2045_CR22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"1000 Genomes Project Consortium, Auton A, Brooks LD, et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374.","journal-title":"Nature"},{"key":"2045_CR23","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.cell.2016.10.026","volume":"167","author":"L Chen","year":"2016","unstructured":"Chen L, Ge B, Casale FP, et al. Genetic drivers of epigenetic and transcriptional variation in human immune cells. Cell. 2016;167:1398-1414.e24.","journal-title":"Cell"},{"key":"2045_CR24","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"GTEx Consortium","year":"2013","unstructured":"GTEx Consortium. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45:580\u20135.","journal-title":"Nat Genet"},{"key":"2045_CR25","volume-title":"ALFA: allele frequency aggregator","author":"L Phan","year":"2020","unstructured":"Phan L, Jin Y, Zhang H, Qiang W, et al. ALFA: allele frequency aggregator. USA: National Center for Biotechnology Information, U.S. National Library of Medicine; 2020."},{"key":"2045_CR26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1471-4159.2007.04758.x","volume":"103","author":"J Burr\u00e9","year":"2007","unstructured":"Burr\u00e9 J, Zimmermann H, Volknandt W. Identification and characterization of SV31, a novel synaptic vesicle membrane protein and potential transporter. J Neurochem. 2007;103:276\u201387.","journal-title":"J Neurochem"},{"key":"2045_CR27","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.108166","volume":"677","author":"VB Sanchez","year":"2019","unstructured":"Sanchez VB, Ali S, Escobar A, et al. Transmembrane 163 (TMEM163) protein effluxes zinc. Arch Biochem Biophys. 2019;677: 108166.","journal-title":"Arch Biochem Biophys"},{"key":"2045_CR28","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2337\/db12-0406","volume":"62","author":"R Tabassum","year":"2013","unstructured":"Tabassum R, Chauhan G, Dwivedi OP, et al. Genome-wide association study for type 2 diabetes in Indians identifies a new susceptibility locus at 2q21. Diabetes. 2013;62:977\u201386.","journal-title":"Diabetes"},{"key":"2045_CR29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls MA, Pankratz N, Lill CM, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat Genet. 2014;46:989\u201393.","journal-title":"Nat Genet"},{"key":"2045_CR30","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18:1091\u2013102.","journal-title":"Lancet Neurol"},{"key":"2045_CR31","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.bbrc.2019.11.117","volume":"522","author":"S Chakraborty","year":"2020","unstructured":"Chakraborty S, Vellarikkal SK, Sivasubbu S, et al. Role of Tmem163 in zinc-regulated insulin storage of MIN6 cells: Functional exploration of an Indian type 2 diabetes GWAS associated gene. Biochem Biophys Res Commun. 2020;522:1022\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"2045_CR32","volume":"31","author":"EJ Salm","year":"2020","unstructured":"Salm EJ, Dunn PJ, Shan L, et al. TMEM163 regulates ATP-gated P2X receptor and behavior. Cell Rep. 2020;31: 107704.","journal-title":"Cell Rep"},{"key":"2045_CR33","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1182\/blood.2020007389","volume":"137","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, Liu T, Huang X, et al. A zinc transporter, transmembrane protein 163, is critical for the biogenesis of platelet dense granules. Blood. 2021;137:1804\u201317.","journal-title":"Blood"},{"key":"2045_CR34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.autrev.2014.11.008","volume":"14","author":"P Bonaventura","year":"2015","unstructured":"Bonaventura P, Benedetti G, Albar\u00e8de F, et al. Zinc and its role in immunity and inflammation. Autoimmun Rev. 2015;14:277\u201385.","journal-title":"Autoimmun Rev"},{"key":"2045_CR35","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1152\/physrev.00035.2014","volume":"95","author":"T Kambe","year":"2015","unstructured":"Kambe T, Tsuji T, Hashimoto A, et al. The physiological, biochemical, and molecular roles of zinc transporters in zinc homeostasis and metabolism. Physiol Rev. 2015;95:749\u201384.","journal-title":"Physiol Rev"},{"key":"2045_CR36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cld.2018.03.007","volume":"22","author":"A Goel","year":"2018","unstructured":"Goel A, Kim WR. Natural history of primary biliary cholangitis in the ursodeoxycholic acid era: role of scoring systems. Clin Liver Dis. 2018;22:563\u201378.","journal-title":"Clin Liver Dis"},{"key":"2045_CR37","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.14309\/ajg.0000000000000290","volume":"114","author":"C Efe","year":"2019","unstructured":"Efe C, Ta\u015f\u00e7ilar K, Henriksson I, et al. Validation of risk scoring systems in ursodeoxycholic acid-treated patients with primary biliary cholangitis. Am J Gastroenterol. 2019;114:1101\u20138.","journal-title":"Am J Gastroenterol"},{"key":"2045_CR38","volume":"8","author":"KS Cheung","year":"2017","unstructured":"Cheung KS, Seto WK, Fung J, et al. Prognostic factors for transplant-free survival and validation of prognostic models in Chinese patients with primary biliary cholangitis receiving ursodeoxycholic acid. Clin Transl Gastroenterol. 2017;8: e100.","journal-title":"Clin Transl Gastroenterol"},{"key":"2045_CR39","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/apt.13927","volume":"45","author":"F Yang","year":"2017","unstructured":"Yang F, Yang Y, Wang Q, et al. The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210. Aliment Pharmacol Ther. 2017;45:733\u201343.","journal-title":"Aliment Pharmacol Ther"},{"key":"2045_CR40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.23637","volume":"52","author":"MG Silveira","year":"2010","unstructured":"Silveira MG, Brunt EM, Heathcote J, et al. American Association for the study of liver diseases endpoints conference: design and endpoints for clinical trials in primary biliary cirrhosis. Hepatology. 2010;52:349\u201359.","journal-title":"Hepatology"},{"key":"2045_CR41","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/apt.15533","volume":"50","author":"CF Murillo Perez","year":"2019","unstructured":"Murillo Perez CF, Hirschfield GM, Corpechot C, et al. Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response. Aliment Pharmacol Ther. 2019;50:1127\u201336.","journal-title":"Aliment Pharmacol Ther"},{"key":"2045_CR42","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jhep.2022.06.017","volume":"77","author":"C Corpechot","year":"2022","unstructured":"Corpechot C, Carrat F, Gaouar F, et al. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis. J Hepatol. 2022;77:1545\u201353.","journal-title":"J Hepatol"},{"key":"2045_CR43","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jhep.2020.11.024","volume":"74","author":"C Bianco","year":"2021","unstructured":"Bianco C, Jamialahmadi O, Pelusi S, et al. Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores. J Hepatol. 2021;74:775\u201382.","journal-title":"J Hepatol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-023-02045-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-023-02045-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-023-02045-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T16:08:47Z","timestamp":1704298127000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-023-02045-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["2045"],"URL":"https:\/\/doi.org\/10.1007\/s00535-023-02045-z","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"type":"print","value":"0944-1174"},{"type":"electronic","value":"1435-5922"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"assertion":[{"value":"12 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicting financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}